Mutation of the SUMOylation sites in eIF5A1 counteracts the proproliferative and promigratory effects of eIF5A1 overexpression on pancreatic ductal adenocarcinoma cells. Here, EIF5A is linked to pancreatic ductal adenocarcinoma.